MORGAN STANLEY PLC/CALL/MERCK & CO./170/0.1/21.03.25 Share Price

Warrant

DE000MB8B1L3

Market Closed - Börse Stuttgart 19:14:09 20/05/2024 BST
0.121 EUR +10.00% Intraday chart for MORGAN STANLEY PLC/CALL/MERCK & CO./170/0.1/21.03.25
Current month-14.18%
1 month-6.20%
Date Price Change
20/05/24 0.121 +10.00%
17/05/24 0.11 -5.98%
16/05/24 0.117 -5.65%
15/05/24 0.124 +18.10%
14/05/24 0.105 -2.78%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 07:14 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MB8B1L
ISINDE000MB8B1L3
Date issued 04/07/2023
Strike 170 $
Maturity 21/03/2025 (305 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.21
Lowest since issue 0.03
Spread 0.004
Spread %3.28%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131 USD
Average target price
141.6 USD
Spread / Average Target
+8.13%
Consensus